MiR-153-3p Suppresses Cell Proliferation, Invasion and Glycolysis of Thyroid Cancer Through Inhibiting E3F3 Expression

References

• Marina N, Nikiforova YEN. Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn. 2008;8(1):83–95. doi:10.1586/14737159.8.1.83
   PubMed Web of Science ®Google Scholar
• Hussain F, Iqbal S, Mehmood A, Bazarbashi S, Elhassan T. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000–2010. Hematol Oncol Stem Cell Ther. 2013;6(2):58–64. doi:10.1016/j.hemonc.2013.05.004
   PubMedGoogle Scholar
• Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res. 2015;8(1):8. doi:10.1186/s13044-015-0020-8
   PubMedGoogle Scholar
• Brozzi F, Rago T, Bencivelli W. Salivary glands ultrasound examination after radioiodine-131 treatment for differentiated thyroid cancer. J Endocrinol Invest. 2013;36(3):153–156.
   PubMed Web of Science ®Google Scholar
• Teama SH, Agwa SHA, Fawzy A, Sayed MM, Ibrahim WA, Eid YM. Molecular detection of circulating thyroid specific transcripts (TSHR/Tg-mRNAs) in thyroid cancer patients: their diagnostic significance. Egyptian J Med Human Gene. 2011;12:201–209. doi:10.1016/j.ejmhg.2011.08.002
   Google Scholar
• Wang Y, Yu Y, Tsuyada A, et al. Transforming growth factor-Î2 regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene. 2011;30(12):1470–1480. doi:10.1038/onc.2010.531
   PubMed Web of Science ®Google Scholar
• Oberg AL, French AJ, Sarver AL, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One. 2011;6(6):e20465. doi:10.1371/journal.pone.0020465
   PubMed Web of Science ®Google Scholar
• Zhibin H, Jiaping C, Xiaoyi Z. Genetic variants of miRNA sequences and non–small cell lung cancer survival. J Clin Invest. 2008.
   Web of Science ®Google Scholar
• Mittal A, Chitkara D, Behrman SW. Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer. Biomaterials. 2014;35(25):7077–7087. doi:10.1016/j.biomaterials.2014.04.053
   PubMed Web of Science ®Google Scholar
• Lodewijk L. The value of miRNA in diagnosing thyroid cancer: A systematic review. Cancer Biomarkers. 2012;11(6):229–238. doi:10.3233/CBM-2012-0273
   PubMed Web of Science ®Google Scholar
• Tomasz S, Danuta G. Differences in miRNA and mRNA profile of papillary thyroid cancer variants. Int J Endocrinol. 2016;2016::1–10.
   Web of Science ®Google Scholar
• Pallante P, Federico A, Berlingieri MT, et al. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res. 2008;68(16):6770–6778. doi:10.1158/0008-5472.CAN-08-0695
   PubMed Web of Science ®Google Scholar
• Mardente S, Mari E, Consorti F. HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncol Rep. 2012;28(6):2285–2289. doi:10.3892/or.2012.2058
   PubMed Web of Science ®Google Scholar
• Keutgen XM, Filicori F, Crowley MJ, et al. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clinical Cancer Research. 2011;213(3):S28–S29.
   Google Scholar
• Wu Z, He B, He J. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate. 2013;73(6):596–604. doi:10.1002/pros.22600
   PubMed Web of Science ®Google Scholar
• Varhaug JE, Segadal E, Heimann P. The utility of fine needle aspiration biopsy cytology in the management of thyroid tumors. World J Surg. 1981;5(4):573–577. doi:10.1007/BF01655012
   PubMedGoogle Scholar
• Li L, Lai X, Yuan C, et al. Aberrant expression of miR153 is associated with the poor prognosis of cervical cancer. Oncol Lett. 2018;15::9183–9187.
   Google Scholar
• Donglei L, Min G. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis. Biomedicine Pharmacotherapy. 2019.
   Web of Science ®Google Scholar
• Luan W, Shi Y, Zhou Z, Xia Y. circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axis. Biochem Biophys Res Commun. 2018;502(1):22–29. doi:10.1016/j.bbrc.2018.05.114
   PubMed Web of Science ®Google Scholar
• Leinan Q, Weixin J, Duan G. LncRNA cancer susceptibility candidate 15 accelerates the breast cancer cells progression via miR-153-3p/KLF5 positive feedback loop. Biochem Biophys Res Commun. 2018.
   Web of Science ®Google Scholar
• Zhenghui C, Zhiyan L, Zimei L, Liuhong S. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. J Gene Medicine. 2019.
   Web of Science ®Google Scholar
• Joo LJS, Weiss J, Gill AJ, Clifton-Bligh R. Abstract 501: A RET-related microRNA, miR-153-3p, acts as a tumor suppressor in medullary thyroid carcinoma (MTC) via S6K signaling. Cancer Res. 2018;78(13 Supplement):501.
   PubMed Web of Science ®Google Scholar
• Arciuch VGA. Abstract 2326: S6K activation is essential for the development of follicular thyroid cancer. Cancer Res. 2013;73(8 Supplement):2326.
   Google Scholar
• Wei H, Feng Y, Liang J, et al. Abstract 10616: mir-128 targets E2f3 to regulate cardiomyocyte cell cycle re-entry. Circulation. 2013;22:A10616.
   Google Scholar
• Zhao Y, Zhao Z, Wu F, Wang D. Evaluation of peripheral blood E2F3 mRNA as a potential diagnostic biomarker in human papillary thyroid cancer. ResearchGate.2020. doi:10.21203/rs.3.rs-58122/v1
   Google Scholar
• Vormbrock K, Schreiber C, Loddenkemper C. Abstract C36: using the Rb/E2f3 mutant mouse model to reveal markers for the progression to metastasis. Cancer Res. 2009;69(23 Supplement):C36–C36.
   Google Scholar
• Xue C, Cheng Y, Wu J, Ke K. Circular RNA CircPRMT5 accelerates proliferation and invasion of papillary thyroid cancer through regulation of miR-30c/E2F3 Axis. Cancer Manag Res. 2020;12:3285–3291. doi:10.2147/CMAR.S249237
   PubMed Web of Science ®Google Scholar
• Singh S, Choudhury M. Diagnostic utility of ki67 and p53 immunostaining on solitary thyroid nodule - A cytohistological and radionuclide scintigraphic study. Indian J Pathol Microbiol. 2011;54:472. doi:10.4103/0377-4929.85077
   PubMed Web of Science ®Google Scholar
• Tisell LE, Oden A, Muth A, Altiparmak G, M?Lne J, Ahlman H. The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br J Cancer. 2003;89(11):2093–2097. doi:10.1038/sj.bjc.6601453
   PubMed Web of Science ®Google Scholar
• Deng WK. Expression of smac and ki67 in thyroid carcinoma and its clinical significance. Cancer Res Prevention Treatment. 2008.
   Google Scholar
• Rashtak S, Demars CJ, Lomberk GA, Stein R, Urrutia RA. M1747 Knockout of KLF11, a tumor suppressor for pancreatic cancer, displays an abnormal glucose metabolism. Gastroenterology. 2009;136(5):A–423. doi:10.1016/S0016-5085(09)61947-8
   Web of Science ®Google Scholar
• Li Y, Xu Q, Yang W, Wu T, Lu X. Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells. Gene. 2019;712:143956. doi:10.1016/j.gene.2019.143956
   PubMed Web of Science ®Google Scholar